Prilocaine Hydrochloride

CHEMBL1200586 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
256.8 g/mol
LogP
Phase
4

Prilocaine hydrochloride is the hydrochloride salt form of prilocaine, an amide local anesthetic that blocks voltage-gated sodium channels used for regional anesthesia and in combination topical anesthetic preparations. See prilocaine for complete pharmacological details.

Masse moléculaire

256,7700 g/mol

TPSA

41,10 Ų

Aires thérapeutiques

Mécanisme d'action

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCNC(C)C(=O)Nc1ccccc1C.Cl

InChI

InChI=1S/C13H20N2O.ClH/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2;/h5-8,11,14H,4,9H2,1-3H3,(H,15,16);1H

Molecular Formula

C13H21ClN2O

HBD / HBA

3 / 2

Liaisons Rotatives

5

Atomes Lourds

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Prilocaine hydrochloride is the hydrochloride salt form of prilocaine, an amide local anesthetic that blocks voltage-gated sodium channels used for regional anesthesia and in combination topical anesthetic preparations. See prilocaine for complete pharmacological details.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Prilocaine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200586. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 92163. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.